NCT00539825View on ClinicalTrials.gov

Effect of GSK704838 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

GSK704838

Trial Locations (1)

HA1 3UJ

GSK Investigational Site, Harrow

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00539825 - Effect of GSK704838 In Healthy Volunteers | Biotech Hunter | Biotech Hunter